Dewaraja Y - Search Results

1

Current Status of Radiopharmaceutical Therapy.

St James S, Bednarz B, Benedict S, Buchsbaum JC, Dewaraja Y, Frey E, Hobbs R, Grudzinski J, Roncali E, Sgouros G, Capala J, Xiao Y. St James S, et al. Among authors: dewaraja y. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):891-901. doi: 10.1016/j.ijrobp.2020.08.035. Epub 2020 Aug 14. Int J Radiat Oncol Biol Phys. 2021. PMID: 32805300 Free PMC article. Review.

2

A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.

Ljungberg M, Sjögreen K, Liu X, Frey E, Dewaraja Y, Strand SE. Ljungberg M, et al. Among authors: dewaraja y. J Nucl Med. 2002 Aug;43(8):1101-9. J Nucl Med. 2002. PMID: 12163637 Free PMC article.

3

3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations.

Ljungberg M, Frey E, Sjögreen K, Liu X, Dewaraja Y, Strand SE. Ljungberg M, et al. Among authors: dewaraja y. Cancer Biother Radiopharm. 2003 Feb;18(1):99-107. doi: 10.1089/108497803321269377. Cancer Biother Radiopharm. 2003. PMID: 12667313

4

Recovery of total I-131 activity within focal volumes using SPECT and 3D OSEM.

Koral KF, Yendiki A, Dewaraja YK. Koral KF, et al. Phys Med Biol. 2007 Feb 7;52(3):777-90. doi: 10.1088/0031-9155/52/3/017. Epub 2007 Jan 16. Phys Med Biol. 2007. PMID: 17228120 Free article.

5

Regularized reconstruction in quantitative SPECT using CT side information from hybrid imaging.

Dewaraja YK, Koral KF, Fessler JA. Dewaraja YK, et al. Phys Med Biol. 2010 May 7;55(9):2523-39. doi: 10.1088/0031-9155/55/9/007. Epub 2010 Apr 14. Phys Med Biol. 2010. PMID: 20393233 Free PMC article.

6

Koral receives 2011 Loevinger-Berman Award.

Dewaraja YK, Sgouros G. Dewaraja YK, et al. J Nucl Med. 2011 Dec;52(12):20N. J Nucl Med. 2011. PMID: 22144511 Free article. No abstract available.

7

MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy.

Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, Ljungberg M. Dewaraja YK, et al. J Nucl Med. 2012 Aug;53(8):1310-25. doi: 10.2967/jnumed.111.100123. Epub 2012 Jun 28. J Nucl Med. 2012. PMID: 22743252 Free PMC article.

8

Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activity.

Schipper MJ, Koral KF, Avram AM, Kaminski MS, Dewaraja YK. Schipper MJ, et al. Cancer Biother Radiopharm. 2012 Sep;27(7):403-11. doi: 10.1089/cbr.2011.1053. Cancer Biother Radiopharm. 2012. PMID: 22947086 Free PMC article.

9

Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parameters.

Roberson PL, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK. Roberson PL, et al. Cancer Biother Radiopharm. 2014 Feb;29(1):26-33. doi: 10.1089/cbr.2012.1467. Epub 2013 Oct 8. Cancer Biother Radiopharm. 2014. PMID: 24102174 Free PMC article.

10

MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications.

Dewaraja YK, Ljungberg M, Green AJ, Zanzonico PB, Frey EC; SNMMI MIRD Committee; Bolch WE, Brill AB, Dunphy M, Fisher DR, Howell RW, Meredith RF, Sgouros G, Wessels BW. Dewaraja YK, et al. J Nucl Med. 2013 Dec;54(12):2182-8. doi: 10.2967/jnumed.113.122390. Epub 2013 Oct 15. J Nucl Med. 2013. PMID: 24130233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page